China SXT Pharmaceuticals, Inc.’s $10.2 Million Initial Public Offering

Ambrogio Visconti

Hunter Taubman Fischer & Li advised China SXT Pharmaceuticals on the transaction China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now